Singapore markets closed

Barinthus Biotherapeutics plc (BRNS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.3500-0.0800 (-3.29%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-70,656
-73,347
5,342
-50,865
-17,706
Depreciation & amortisation
5,638
5,429
4,323
602
208
Deferred income taxes
-2,596
-3,075
-4,337
-119
0
Stock-based compensation
4,448
5,055
9,877
16,487
3,625
Change in working capital
-798
6,171
-5,524
-7,178
1,922
Accounts receivable
839
5,800
-5,833
559
479
Accounts payable
-2,195
-3,378
1,140
-3,528
586
Other working capital
-62,787
-56,338
-20,569
-33,729
-11,321
Other non-cash items
1,478
1,411
1,162
1,151
3,637
Net cash provided by operating activities
-59,573
-50,925
-14,431
-32,583
-11,028
Cash flows from investing activities
Investments in property, plant and equipment
-3,214
-5,413
-6,138
-1,146
-293
Acquisitions, net
-
-
0
-11,766
0
Net cash used for investing activities
-3,214
-5,413
-5,750
-12,912
-293
Cash flows from financing activities
Debt repayment
-
0
-159
0
-
Common stock issued
749
2,035
484
102,774
0
Other financing activities
-
-163
-
-5,271
194
Net cash used provided by (used for) financing activities
686
1,872
325
222,742
41,435
Net change in cash
-61,357
-52,295
-19,669
170,788
31,834
Cash at beginning of period
191,328
194,385
214,054
43,266
11,432
Cash at end of period
129,227
142,090
194,385
214,054
43,266
Free cash flow
Operating cash flow
-59,573
-50,925
-14,431
-32,583
-11,028
Capital expenditure
-3,214
-5,413
-6,138
-1,146
-293
Free cash flow
-62,787
-56,338
-20,569
-33,729
-11,321